structure of 5(6)-Dehydro-4(5)-dihydro D-(-)-Norgestrel

5(6)-Dehydro-4(5)-dihydro D-(-)-Norgestrel

CAS No.: 100021-05-4
M. Wt: 312.44600
M. Fa: C21H28O2
InChI Key: LYRBZVWRTAFWPO-XUDSTZEESA-N

Names and Identifiers of 100021-05-4

CAS Number

100021-05-4

IUPAC Name

(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,4,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one

InChI

InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,5,16-19,23H,3,6-13H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1

InChIKey

LYRBZVWRTAFWPO-XUDSTZEESA-N

Canonical SMILES

CCC12CCC3C4CCC(=O)CC4=CCC3C1CCC2(C#C)O

Isomeric SMILES

CC[C@]12CC[C@@H]3[C@H]4CCC(=O)CC4=CC[C@H]3[C@@H]1CC[C@]2(C#C)O

UNII

QV7HH25Q8V

Physical and chemical properties of 100021-05-4

Acidity coefficient

13.10±0.40(Predicted)

Boiling Point

451.8±45.0 °C(Predicted)

Density

1.13±0.1 g/cm3(Predicted)

Exact Mass

312.20900

LogP

3.88260

Melting Point

>189°C (dec.)

Molecular Formula

C21H28O2

Molecular Weight

312.44600

PSA

37.30000

Solubility

Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)

Storage condition

Amber Vial, -20°C Freezer, Under Inert Atmosphere

Applications of 100021-05-4

5(6)-Dehydro-4(5)-dihydro D-(-)-Norgestrel is primarily used in:

  • Hormonal Contraceptives: It is a key ingredient in various oral contraceptive formulations.
  • Hormone Replacement Therapy: The compound may be utilized in therapies aimed at alleviating symptoms associated with menopause.
  • Menstrual Disorder Treatments: It is effective in managing conditions like dysmenorrhea and endometriosis.

These applications underscore its significance in women's health.

Interaction Studies of 100021-05-4

Research on interaction studies involving 5(6)-Dehydro-4(5)-dihydro D-(-)-Norgestrel has shown that it can interact with various other drugs:

  • Enzyme Inhibitors: Certain medications that inhibit cytochrome P450 enzymes may affect the metabolism of this compound, leading to altered efficacy or increased side effects.
  • Antibiotics: Some antibiotics can reduce the effectiveness of hormonal contraceptives, necessitating careful monitoring when co-administered.

Understanding these interactions is vital for optimizing therapeutic regimens involving this progestin.

Biological Activity of 100021-05-4

The primary biological activity of 5(6)-Dehydro-4(5)-dihydro D-(-)-Norgestrel lies in its progestational effects. It mimics the action of progesterone in the body, influencing various physiological processes:

  • Endometrial Regulation: It plays a crucial role in preparing the endometrium for potential implantation of an embryo.
  • Contraceptive Effects: By inhibiting ovulation and altering cervical mucus, it serves as an effective contraceptive agent.
  • Menstrual Cycle Regulation: The compound is also used to manage menstrual disorders by stabilizing hormonal fluctuations.

The potency and efficacy of this compound make it a valuable agent in reproductive health.

Retrosynthesis analysis of 100021-05-4

  • Route#1

    Cas:434-03-7
    Cas:100021-05-4
  • Route#2

    Cas:797-63-7
    Cas:100021-05-4